Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer
May 29, 2024 09:00 ET
|
WaveDancer, Inc.
FAIRFAX, Va. and TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”), a pioneering artificial intelligence (“AI”) company developing innovative neuroscientific solutions...
Launch Manifest Database of the Main Launch Vehicles Market Players 2024 Featuring SpaceX, blue Origin, Firefly, Gilmour Space, Orbex, Virgin Galactic, & ISRO Among Others
May 22, 2024 08:30 ET
|
Research and Markets
Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Launch Manifest of the Main Launch Vehicles Market Players - Q1, 24" report has been added to ResearchAndMarkets.com's offering. This report provides...
BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™
May 20, 2024 07:30 ET
|
BrightSpring Health Services, Inc.
LOUISVILLE, Ky., May 20, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that its company, Onco360®, one of the...
The BAM Companies: A Portrait of Success and Culture in Indiana
May 16, 2024 17:37 ET
|
BAM Capital
Indianapolis, May 16, 2024 (GLOBE NEWSWIRE) -- Indianapolis, Indiana - In the bustling realm of real estate investment and management, The BAM Companies stands out for its robust growth and...
KULR Technology Group Reports First Quarter 2024 Financial Results
May 15, 2024 16:15 ET
|
KULR Technology Group, Inc.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a global leader in sustainable energy management, today reported results for...
Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, David Johnson as Executive Chairman, Upon Closing of Its Merger Transaction with WaveDancer
May 14, 2024 09:00 ET
|
WaveDancer, Inc.
FAIRFAX, Va. And TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”), a pioneering artificial intelligence (“AI”) company developing innovative neuroscientific solutions...
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
May 06, 2024 16:30 ET
|
Day One Biopharmaceuticals, Inc.
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions received in the U.S. ...
KULR Technology Group Lends Battery Production Infrastructure for Rapid Support of NASA's R5 Program
May 02, 2024 08:30 ET
|
KULR Technology Group, Inc.
KULR’s New Texas Battery Center of Excellence Facility Demonstrates Fast Turn-Around Time for Customers
OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation
April 29, 2024 07:30 ET
|
Onco360 Oncology Pharmacy
LOUISVILLE, Ky., April 29, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDA™...
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
April 23, 2024 15:56 ET
|
Day One Biopharmaceuticals, Inc.
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Co